Business Segments · Operating Earnings
Diagnostic Products — Operating Earnings
Abbott Diagnostic Products — Operating Earnings decreased by 45.0% to $335.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.7%, from $359.00M to $335.00M. Over 4 years (FY 2021 to FY 2025), Diagnostic Products — Operating Earnings shows a downward trend with a -27.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toOperating Income
How to read this metric
Higher earnings indicate strong operational performance and effective cost control within the segment.
Detailed definition
The profit generated from the diagnostics segment after subtracting operating expenses from net sales. This is the prima...
Peer comparison
Standard segment-level operating profit metric.
Metric ID:
abt_segment_diagnostic_products_operating_earningsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.1B | 1.7B | 1.8B | 2.6B | 1.7B | 1.4B | 1B | 651M | 437M | 632M | 713M | 474M | 430M | 558M | 611M | 359M | 372M | 400M | 609M | 335M |
| QoQ Change | — | +53.5% | +10.6% | +40.6% | -33.4% | -20.9% | -23.4% | -37.2% | -32.9% | +44.6% | +12.8% | -33.5% | -9.3% | +29.8% | +9.5% | -41.2% | +3.6% | +7.5% | +52.3% | -45.0% |
| YoY Change | — | — | — | — | +58.9% | -18.2% | -43.3% | -74.7% | -74.4% | -53.3% | -31.2% | -27.2% | -1.6% | -11.7% | -14.3% | -24.3% | -13.5% | -28.3% | -0.3% | -6.7% |
Range335M – 2.6B
CAGR-21.8%
Avg YoY Growth-22.7%
Median YoY Growth-21.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's diagnostic products — operating earnings?
- Abbott (ABT) reported diagnostic products — operating earnings of $335.00M in Q1 2026.
- How has Abbott's diagnostic products — operating earnings changed year-over-year?
- Abbott's diagnostic products — operating earnings decreased by 6.7% year-over-year, from $359.00M to $335.00M.
- What is the long-term trend for Abbott's diagnostic products — operating earnings?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — operating earnings has grown at a -27.4% compound annual growth rate (CAGR), from $6.26B to $1.74B.
- What does diagnostic products — operating earnings mean?
- Profit from the diagnostics business before interest and taxes.